Massachusetts Financial Services’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-213,851
| Closed | -$21.2M | – | 862 |
|
|
2019
Q3 | $21.2M | Sell |
213,851
-20,192
| -9% | -$1.92M | 0.01% | 520 |
|
|
2019
Q2 | $21.6M | Sell |
234,043
-32,003
| -12% | -$3.04M | 0.01% | 527 |
|
|
2019
Q1 | $25.1M | Sell |
266,046
-714,986
| -73% | -$62.5M | 0.01% | 498 |
|
|
2018
Q4 | $62.9M | Buy |
981,032
+4,669
| +0.5% | +$345K | 0.03% | 350 |
|
|
2018
Q3 | $87.4M | Sell |
976,363
-121,900
| -11% | -$10.8M | 0.04% | 311 |
|
|
2018
Q2 | $87.2M | Sell |
1,098,263
-888,209
| -45% | -$73.7M | 0.04% | 299 |
|
|
2018
Q1 | $177M | Sell |
1,986,472
-1,797,199
| -47% | -$173M | 0.08% | 212 |
|
|
2017
Q4 | $395M | Sell |
3,783,671
-670,064
| -15% | -$75.6M | 0.17% | 147 |
|
|
2017
Q3 | $649M | Sell |
4,453,735
-1,208,303
| -21% | -$165M | 0.28% | 99 |
|
|
2017
Q2 | $735M | Sell |
5,662,038
-477,504
| -8% | -$58.5M | 0.33% | 91 |
|
|
2017
Q1 | $764M | Buy |
6,139,542
+624,233
| +11% | +$74.7M | 0.36% | 82 |
|
|
2016
Q4 | $638M | Buy |
5,515,309
+156,859
| +3% | +$17.5M | 0.31% | 94 |
|
|
2016
Q3 | $560M | Buy |
5,358,450
+287,123
| +6% | +$31.1M | 0.27% | 101 |
|
|
2016
Q2 | $500M | Buy |
5,071,327
+413,878
| +9% | +$42.8M | 0.25% | 113 |
|
|
2016
Q1 | $466M | Buy |
4,657,449
+569,768
| +14% | +$58.7M | 0.24% | 117 |
|
|
2015
Q4 | $490M | Buy |
4,087,681
+386,791
| +10% | +$44.7M | 0.26% | 101 |
|
|
2015
Q3 | $400M | Buy |
3,700,890
+1,756,905
| +90% | +$218M | 0.22% | 114 |
|
|
2015
Q2 | $225M | Buy |
1,943,985
+91,215
| +5% | +$10.4M | 0.11% | 172 |
|
|
2015
Q1 | $214M | Sell |
1,852,770
-666,341
| -26% | -$79.6M | 0.11% | 181 |
|
|
2014
Q4 | $282M | Sell |
2,519,111
-119,153
| -5% | -$12.6M | 0.14% | 151 |
|
|
2014
Q3 | $250M | Buy |
2,638,264
+150,279
| +6% | +$13.6M | 0.13% | 160 |
|
|
2014
Q2 | $214M | Buy |
2,487,985
+21,467
| +0.9% | +$1.63M | 0.11% | 175 |
|
|
2014
Q1 | $172M | Sell |
2,466,518
-1,040,640
| -30% | -$82.4M | 0.09% | 184 |
|
|
2013
Q4 | $296M | Sell |
3,507,158
-1,940,736
| -36% | -$154M | 0.17% | 131 |
|
|
2013
Q3 | $420M | Buy |
5,447,894
+984,430
| +22% | +$69M | 0.26% | 88 |
|
|
2013
Q2 | $261M | Buy |
+4,463,464
| New | +$269M | 0.18% | 125 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Massachusetts Financial Services's CELG Position: Q4 2019 in Review
Massachusetts Financial Services sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 213,851 shares — an estimated $21.2M sold.
Massachusetts Financial Services first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $764M in Q1 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Massachusetts Financial Services reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Massachusetts Financial Services sold 213,851 Celgene Corp shares in Q4 2019, an estimated $21.2M.
- Massachusetts Financial Services first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Massachusetts Financial Services's Celgene Corp position peaked at $764M in Q1 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Massachusetts Financial Services's 13F filing for Q4 2019, filed 13 Feb 2020.